Skip to main content
SpringerLink
Log in

If Ischemic Preconditioning Is the Gold Standard, Has a Platinum Standard of Cardioprotection Arrived? Comparison with NHE Inhibition

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Murry C, Jennings R, Reimer K. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124–1136.

    Google Scholar 

  2. Meldrum D. Mechanisms of cardiac preconditioning: Ten years after the discovery of ischemic preconditioning. J Surgi Res 1997;73:1–13.

    Google Scholar 

  3. Gross G, Auchampach J. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223–233.

    Google Scholar 

  4. Auchampach J, Gross G. Adenosine A1 receptors, KATP channels and ischemic preconditioning. Am J Physiol 1993;264:H1327–H1336.

    Google Scholar 

  5. Ytrehus K, Liu Y, Downey L. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145–H1152.

    Google Scholar 

  6. Maulik N, Watanabe M, Zu Y-L, Huang C-K, Cordis G, Schley J, Das D. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996;396:233–237.

    Google Scholar 

  7. Vahlhaus C, Schulz R, Post H, Rose J, Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and tyrosine kinase in pigs. J Mol Cell Cardiol 1998;30:197–209.

    Google Scholar 

  8. Karmazyn M. The sodium-hydrogen exchange system in the heart: Its role in ischemic and reperfusion injury and therapeutic implications. Can J Cardiol 1996;12:1074–1082.

    Google Scholar 

  9. Orlowski J, Kandasamy R, Schull G. Molecular cloning of putative members of the Na+/H+ exchanger gene family —cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of the rat Na+/H+ exchanger NHE-1 and two structurally related proteins. J Biol Chem 1992;267:9331–9339.

    Google Scholar 

  10. Murry C, Richard V, Reimer K, Jennings R. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913–931.

    Google Scholar 

  11. Kida M, Fujiwara H, Ishida M, Kawai C, Ohura M, Miura I, Yabuuchi Y. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 1991;84:2495–2503.

    Google Scholar 

  12. Asimakis G, Inners-McBride K, Medellin G, Conti V. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol 1992;63:H887–H894.

    Google Scholar 

  13. Wolfe C, Sievers R, Visseren F, Donnelly T. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 1993;87:881–892.

    Google Scholar 

  14. Steenbergen C, Perlman M, London R, Murphy E. Mechanism of preconditioning: Ionic alterations. Circ Res 1993;72: 112–125.

    Google Scholar 

  15. Ramasamy R, Liu H, Anderson S, Lundmark J, Schaefer S. Ischemic preconditioning stimulates sodium and proton transport in isolated rat hearts. J Clin Invest 1995;96: 1464–1472.

    Google Scholar 

  16. Frelin C, Vigne P, Lazdunski M. The role of Na+/H+ exchange system in cardiac cells in relation to the control of internal Na+ concentration. A molecular basis for the antagonistic effect of ouabain and amiloride on the heart. J Biol Chem 1984;259:8880–8885.

    Google Scholar 

  17. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985;17:1029–1042.

    Google Scholar 

  18. Poole-Wilson P. Regulation of intracellular pH in the myocardium; relavance to pathology. Mol Cell Biochem 1989;89: 151–155.

    Google Scholar 

  19. Tani M, Neely J. Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res 1989;65:1045–1056.

    Google Scholar 

  20. duToit E, Opie L. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 1992;70:960–967.

    Google Scholar 

  21. Wilde A, Janse M. Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogenesis. Cardiovasc Res 1994;28:16–24.

    Google Scholar 

  22. Miyawaki H, Ashraf M. Ca2+ as a mediator of ischemic preconditioning. Circ Res 1997:790.

  23. Auchampach J, Maruyama M, Cavero I, Gross G. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation 1992;86: 311–319.

    Google Scholar 

  24. Steenbergen C, Perlman M, London R, Murphy E. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 1990;66:135–146.

    Google Scholar 

  25. Mizumura T, Gross G, Schultz J. A new sodium-hydrogen exchange (NHE) inhibitor, EMD 85131, limits infarct size (IS) in dogs independent of adenosine (Ado) or ATP-sensitive potassium (KATP) channels. Circulation 1997;00(Suppl. I):I140.

    Google Scholar 

  26. Sato H, Miki T, Vallabhapurapu R, Wang P, Liu G-S, Cohen M, Downey J. The mechanism of protection from 5 (Nethyl-N-isopropyl)amiloride differs from that of ischemic preconditioning in rabbit heart. Basic Res Cardiol 1997;92: 339–350.

    Google Scholar 

  27. Miura T, Ogawa T, Suzuki K, Goto M, Shimamato K. Infarct size limitation by a new Na+-H+ exchange inhibitor, Hoe 642: Difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol 1997;29:693–701.

    Google Scholar 

  28. Gross G, Schultz J. In dogs tolerant to ischemic preconditioning (IPC), the sodium-hydrogen exchange (NHE) inhibitor, EMD 85131 retains its efficacy to reduce myocardial infarct size (IS). Circulation 1997;00(Suppl. I):I743.

    Google Scholar 

  29. Przyklenk K, Hata K, Kloner R. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium. Circulation 1997;96:1305–1312.

    Google Scholar 

  30. Kleyman T, Cragoe E. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 1988;105:1–21.

    Google Scholar 

  31. Pierce G, Cole W, Liu L, et al. Modulation of cardiac performance by amiloride and several selected derivatives of amiloride. J Pharmacol Exp Ther 1993;265:1280–1291.

    Google Scholar 

  32. Bugge E, Ytrehus K. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart—a protective additive to ischemic preconditioning. Cardiovasc Res 1995;29:269–274.

    Google Scholar 

  33. Shipolini A, Yokoyama H, Galinanes M, Edmondson S, Hearse D, Avkiran M. Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation 1997;96:3617–3625.

    Google Scholar 

  34. Gumina R, Buerger E, Eickmeier C, Daemmgen J, Gross G. Inhibition of the Na+/H+ exchanger: Greater efficacy against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation 1999, in press.

  35. Nao B, McClanahan T, Groh M, Schott R, Gallagher K. The time limit of effective ischemic preconditioning in dogs (abstr). Circulation 1990;82(Suppl. III):III271.

    Google Scholar 

  36. Rohmann S, Weygandt H, Minck K. Preischemic as well as postischemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigs. Cardiovasc Res 1995;30: 945–951.

    Google Scholar 

  37. Gumina R, Mizumura T, Beier N, Schelling P, Schultz J, Gross G. A new Na+/H+ exchange (NHE-1) inhibitor, EMD 85131, limits infarct size in dogs when administered prior to or after coronary artery occlusion. J Pharmacol Exp Ther 1998;286:175–183.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota

    Richard J. Gumina

  2. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Garrett J. Gross

Authors
  1. Richard J. Gumina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Garrett J. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gumina, R.J., Gross, G.J. If Ischemic Preconditioning Is the Gold Standard, Has a Platinum Standard of Cardioprotection Arrived? Comparison with NHE Inhibition. J Thromb Thrombolysis 8, 39–44 (1999). https://doi.org/10.1023/A:1008942614246

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008942614246

Search

Navigation